Pharmafile Logo

Peter Impey

- PMLiVE

Sanofi cuts $925m deal for MannKind’s inhaled insulin

French company bolsters diabetes business with Afrezza collaboration

- PMLiVE

Dancing with the Deval

Allowing states to circumvent FDA drug approvals would set a dangerous precedent

EU flag

International regulators collaborate on generics

EMA leads three-year pilot project to increase pre-market data sharing

- PMLiVE

Wendy Wolf joins Ashfield Healthcare

Takes up role as senior vice president of commercial and clinical operations

- PMLiVE

Pfizer closes on $1bn label expansion for Prevenar

EMA begins review of the pneumococcal vaccine

- PMLiVE

Baxter opens Advate facility in Singapore

Follows EU approval for haemophilia A drug plant

MS market set to grow 4% annually

Predictedto reach $20bn by 2023 partly due to Plegridy and ocrelizumab launches

- PMLiVE

Roche blasts UK’s ‘broken’ HTA system as Kadcyla rejected

But NICE says it is 'very disappointed' with the company's pricing policy

- PMLiVE

emotive continues to grow

London digital agency appoints Aaron Joshua Barroso digital marketing manager

- PMLiVE

Has the biological revolution in rheumatoid arthritis peaked?

In the short term the focus looks set to be on personalised use of existing therapies

- PMLiVE

Janssen looks to NASCAR for atrial fibrillation awareness

Company's MyAFibStory.com 400 kicks off the NASCAR Sprint Cup series

- PMLiVE

Determining value to withstand all tests

The late arrival of an early role for communications

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links